BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan IU, Huang J, Li X, Xie J, Zhu N. Nasal immunization with RSV F and G protein fragments conjugated to an M cell-targeting ligand induces an enhanced immune response and protection against RSV infection. Antiviral Res 2018;159:95-103. [PMID: 30290196 DOI: 10.1016/j.antiviral.2018.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Lemoine C, Thakur A, Krajišnik D, Guyon R, Longet S, Razim A, Górska S, Pantelić I, Ilić T, Nikolić I, Lavelle EC, Gamian A, Savić S, Milicic A. Technological Approaches for Improving Vaccination Compliance and Coverage. Vaccines (Basel) 2020;8:E304. [PMID: 32560088 DOI: 10.3390/vaccines8020304] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
2 Li H, Ren H, Zhang Y, Cao L, Xu W. Intranasal vaccination with a recombinant protein CTA1-DD-RBF protects mice against hRSV infection. Sci Rep 2021;11:18641. [PMID: 34545126 DOI: 10.1038/s41598-021-97535-6] [Reference Citation Analysis]
3 Saraf S, Jain S, Sahoo RN, Mallick S. Present Scenario of M-Cell Targeting Ligands for Oral Mucosal Immunization. CDT 2020;21:1276-84. [DOI: 10.2174/1389450121666200609113252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Xie L, Zai J, Yi K, Li Y. Intranasal immunization with recombinant Vaccinia virus Tiantan harboring Zaire Ebola virus gp elicited systemic and mucosal neutralizing antibody in mice. Vaccine 2019;37:3335-42. [PMID: 31076161 DOI: 10.1016/j.vaccine.2019.04.070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Beugeling M, De Zee J, Woerdenbag HJ, Frijlink HW, Wilschut JC, Hinrichs WLJ. Respiratory syncytial virus subunit vaccines based on the viral envelope glycoproteins intended for pregnant women and the elderly. Expert Rev Vaccines 2019;18:935-50. [PMID: 31446807 DOI: 10.1080/14760584.2019.1657013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
6 Hou S, Xu X, Wang Y, Yang Y. Ephedrannin B exerts anti-viral and anti-inflammatory properties in BEAS-2B cells infected with respiratory syncytial virus. J Biosci 2020;45. [DOI: 10.1007/s12038-020-0016-y] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tripp RA, Stambas J. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses 2021;13:625. [PMID: 33917411 DOI: 10.3390/v13040625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]